Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, everyone. Welcome to Cross Country Healthcare's Earnings Conference Call for the Third Quarter 2024.
Cross Country Healthcare Inc (CCRN)
Market is closed
Sector: Services-Help Supply Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Magnetar Capital Alec Litowitz And Ross Laser | 2,474,331 | $32,290,019 | 0.16% | |
| 2. | Alpine Associates Robert Emil Zoellner | 985,683 | $12,863,164 | -22% | 0.69% |
| 3. | Sand Grove Capital Partners Simon Davies | 321,845 | $4,200,077 | 2.11% | |
| 4. | Weiss Asset Management Andrew Weiss | 315,363 | $4,115,487 | 0.05% | |
| 5. | Renaissance Technologies Jim Simons | 288,983 | $3,771,228 | +66% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.29 | 4,000 | $37,160.00 | 199,632 | 2018-08-10 | Filing | |
| $12.08 | 2,000 | $24,160.00 | 195,632 | 2017-08-28 | Filing | |
| $25.60 | 1,500 | $38,400.00 | 177,899 | 2022-08-30 | Filing | |
| $25.24 | 4,000 | $100,960.00 | 52,039 | 2022-08-24 | Filing | |
| $6.29 | 9,101 | $57,245.29 | 523,704 | 2020-08-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.21 | 1,945 | $33,473.45 | 7,605 | 2024-08-02 | Filing | |
| $17.08 | 13,829 | $236,199.32 | 24,696 | 2024-08-02 | Filing | |
| $14.82 | 13,657 | $202,396.74 | 36,020 | 2024-05-30 | Filing | |
| $14.19 | 9,646 | $136,876.74 | 10,162 | 2024-05-23 | Filing | |
| $16.95 | 6,216 | $105,361.20 | 35,101 | 2024-03-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,714,986 | $35,430,570 | 0% | |
| 2. | 2,438,282 | $31,819,580 | 0.01% | |
| 3. | 1,910,007 | $24,924,869 | 0.01% | |
| 4. | 1,845,658 | $24,085,836 | 0% | |
| 5. | 1,575,000 | $20,553,750 | 0.81% |
News See All
Should You Consider Selling Cross Country Healthcare (CCRN)?
Wasatch Global Investors, an asset management company, released its “Wasatch Micro-Cap Value Strategy” second-quarter 2024 investor letter. A copy of the same can be downloaded here.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q2 2024 Earnings Call Transcript
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q2 2024 Earnings Call Transcript July 31, 2024Cross Country Healthcare, Inc. misses on earnings expectations.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q1 2024 Earnings Call Transcript
Cross Country Healthcare, Inc. misses on earnings expectations. Reported EPS is $0.07781 EPS, expectations were $0.17. Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, everyone. Welcome to Cross Country Healthcare’s Earnings Conference Call for the Fourth Quarter 2023.
Should You Invest in Cross Country Healthcare (CCRN)?
Wasatch Global Investors, an investment management firm, released its “Wasatch Micro Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
12 Best Healthcare Stocks For the Long-Term
In this piece, we will take a look at the 12 best healthcare stocks for the long term.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, everyone. Welcome to Cross Country Healthcare’s Earnings Conference Call for the Third Quarter 2023.
Here's Why Long Cast Advisers Exited Cross Country Healthcare (CCRN)
Long Cast Advisers, LLC, a small-cap-focused investment manager, released its second quarter 2023 investor letter. A copy of the same can be downloaded here.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, everyone. Welcome to Cross Country Healthcare’s Earnings Conference Call for the Second Quarter 2023.
Billionaire Hedge Funds
